Total cure, initial infection (n = 101) | Relapse/reinfection, or chronic infection (n = 30) | P-value | Multivariate P-value | |
---|---|---|---|---|
Median Age, years (IQR) | 28 (23, 41) | 30 (22, 41) | 0.44 | |
Male | 91 (91 %) | 24 (80 %) | 0.14 | NS |
Military Service | 75 (75 %) | 17 (57 %) | 0.06 | NS |
Combat Trauma | 68 (68 %) | 16 (53 %) | 0.16 | NS |
Burn | 38 (38 %) | 14 (47 %) | 0.37 | |
% TBSA burn (IQR) | 53.5 % (28, 60) | 77 % (59, 85) | <0.01 | NS |
Coronary Artery Disease | 3 (3 %) | 0 | 0.34 | |
Chronic Kidney Disease | 0 | 0 | ||
ESRD | 0 | 0 | ||
Diabetes | 6 (6 %) | 5 (17 %) | 0.06 | NS |
Median Hct on Culture Date (IQR) | 24.2 (22, 30) | 23.6 (22, 27) | 0.53 | |
Median WBC on Culture Date (IQR) | 9.7 (7, 13) | 7 (5, 12) | 0.11 | NS |
Median ESR on Culture Date (IQR) | 91.5 (65, 114) | 106 (104, 114) | 0.48 | |
Median CRP on Culture Date (IQR) | 18.9 (7, 21) | 16.1 (9, 30) | 0.14 | NS |
Received Appropriate Empiric Antibiotics | 39 (39 %) | 16 (53 %) | 0.28 | |
Median Prior Duration of Antibiotics, Days (IQR) | 6 (2, 8) | 4 (2, 9) | 0.57 | |
A. calcoaceticus-baumannii complex | 34 (34 %) | 6 (20 %) | 0.41 | |
E. coli | 19 (19 %) | 5 (17 %) | 0.79 | |
K. pneumoniae | 25 (25 %) | 7 (23 %) | 0.87 | |
P. aeruginosa | 9 (9 %) | 7 (23 %) | 0.03 | NS |
S. aureus | 14 (14 %) | 6 (20 %) | 0.41 | |
MSSA | 1 (1 %) | 5 (17 %) | <0.01 | NS |
MRSA | 12 (13 %) | 1 (3 %) | 0.14 | NS |
Polymicrobial Event | 41 (41 %) | 7 (23 %) | 0.09 | NS |
Blood Culture | 23 (23 %) | 11 (37 %) | 0.13 | NS |
Central Line Associated | 9 (39 % n = 23) | 0 | 0.12 | NS |
Respiratory Culture | 4 (4 %) | 4 (13 %) | 0.08 | NS |
Urine Culture | 6 (6 %) | 4 (13 %) | 0.24 | |
Foley Catheter Associated | 2 | 0 | 0.44 | |
Wound Culture | 68 (68 %) | 11 (37 %) | <0.01 | NS |
Orthopedic Device Related | 13 (19 %, n = 68) | 5 (25 %, n = 11) | 0.50 | |
Median Number of Surgeries (IQR) | 7 (4, 9) | 3 (2, 9) | 0.15 | NS |